Chapel Hill, NC, United States of America

Yi Zhang

This inventor holds 14 USPTO granted patents and 13 published patent applications and 4 EPO patents, primarily in Cellular Reprogramming. Top assignees: The University of North Carolina at Chapel Hill, Children's Medical Center Corporation, Boston University. Active years: 2008-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yi Zhang. Retrieved from https://idiyas.com/inventor/yi-zhang-hdkgoxli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14 

% Patents Active = 50.0

 

Average Co-Inventor Count = 2.3

ph-index = 4

Forward Citations = 121(Granted Patents)


Location History:

  • Chapel Hill, NC (US) (2008 - 2014)
  • Newton, MA (US) (2017 - 2022)
  • Boston, MA (US) (2019 - 2023)

Company Filing History:


Years Active: 2008-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Somatic Cell Nuclear Transfer
Histone Methylation
Leukemia Treatment
X Chromosome Inactivation
Fluorescence Microscopy
Imprinting Defects
Ubiquitin E3 Ligase
Therapeutic Agents
Methyltransferases
Diagnostic Targets
Reconstituted Complex
14 patents (USPTO):Explore Patents

Title: Top Inventor in Chapel Hill, NC

Introduction: Gerald H. Negley is a prominent inventor known for his contributions to various fields.

Latest Patents: His recent patents include innovative solutions that address contemporary challenges.

Career Highlights: Throughout his career, Negley has achieved significant milestones that have impacted the industry.

Collaborations: He has worked with various organizations and individuals to further his inventive pursuits.

Conclusion: Gerald H. Negley continues to be a leading figure in the world of innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…